May 01, 2018 - Names on the move ahead of the open.
Sep 12, 2017 - Despite a lack of particularly damaging news, investors are losing patience with this biotech.
Mar 12, 2018 - Names on the move ahead of the open.
Apr 13, 2017 - NewLink Genetics and Incyte Corporation's IDO-inhibitors could be the next big advance in cancer treatment.
Apr 21, 2017 - Merck may be a picture-perfect stock for long-term investors to consider buying.
Apr 25, 2017 - Without price increases or deals to boost earnings, the pharmaceuticals sector faces a weak earnings season.
May 02, 2017 - Merck handily beat expectations with its Q1 results. Here's how the drugmaker did it.
Aug 27, 2017 - Roche, Novartis, Pfizer, Johnson & Johnson, and Merck are investing the heaviest in R&D. That could bode well for these big pharma stocks.
Aug 29, 2017 - A study by Express Scripts points to how diabetes patients can avoid ER visits and hospital stays while potentially keeping more money in their pockets.
Apr 19, 2017 - Does Merck's sizzling-hot cancer drug Keytruda give it a leg up over longtime winner Johnson & Johnson?